QUALCOMM Incorporated's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Sep 28, 2025 · FY), QUALCOMM Incorporated reported revenue of $44.3B (+13.7% year on year) and net income of $5.5B (-45.4% year on year).
| Line item | Sep 28, 2025 · FY | Sep 29, 2024 · FY | Sep 24, 2023 · FY | Sep 25, 2022 · FY |
|---|---|---|---|---|
| Equipment and services | $37.9B | $32.8B | $30.0B | $37.2B |
| Licensing | $6.4B | $6.2B | $5.8B | $7.0B |
| Total revenues | $44.3B | $39.0B | $35.8B | $44.2B |
| Cost of revenues | $19.7B | $17.1B | $15.9B | $18.6B |
| Research and development | $9.0B | $8.9B | $8.8B | $8.2B |
| Selling, general and administrative | $3.1B | $2.8B | $2.5B | $2.6B |
| Other (Note 2) | $39.0M | $179.0M | $862.0M | ($1.1B) |
| Total costs and expenses | $31.9B | $28.9B | $28.0B | $28.3B |
| Operating income | $12.4B | $10.1B | $7.8B | $15.9B |
| Interest expense | ($664.0M) | ($697.0M) | ($694.0M) | ($490.0M) |
| Investment and other income, net | $972.0M | $962.0M | $349.0M | — |
| Income from continuing operations before income taxes | $12.7B | $10.3B | $7.4B | $15.0B |
| Income tax expense | ($7.1B) | ($226.0M) | ($104.0M) | ($2.0B) |
| Income from continuing operations | $5.5B | $10.1B | $7.3B | $13.0B |
| Discontinued operations, net of income taxes | $0 | $32.0M | ($107.0M) | ($50.0M) |
| Net income | $5.5B | $10.1B | $7.2B | $12.9B |
| Basic earnings per share, Continuing operations | $5.05 | $9.06 | $6.57 | $11.56 |
| Basic earnings per share, Discontinued operations | $0.00 | $0.03 | -$0.10 | -$0.04 |
| Earnings Per Share, Basic, Total | $5.05 | $9.09 | $6.47 | $11.52 |
| Diluted earnings per share, Continuing operations | $5.01 | $8.94 | $6.52 | $11.41 |
| Diluted earnings per share, Discontinued operations | $0.00 | $0.03 | -$0.10 | -$0.04 |
| Earnings Per Share, Diluted, Total | $5.01 | $8.97 | $6.42 | $11.37 |
| Basic | 1.1B | 1.1B | 1.1B | 1.1B |
| Diluted | 1.1B | 1.1B | 1.1B | 1.1B |
| Line item | Jun 28, 2026 · Q3 | Mar 29, 2026 · Q2 | Dec 28, 2025 · Q1 | Jun 29, 2025 · Q3 |
|---|---|---|---|---|
| Equipment and services | $8.5B | $9.1B | $10.5B | $8.9B |
| Licensing | $1.5B | $1.5B | $1.8B | $1.5B |
| Total revenues | $9.9B | $10.6B | $12.3B | $10.4B |
| Cost of revenues | $4.7B | $4.9B | $5.6B | $4.6B |
| Research and development | $2.6B | $2.5B | $2.5B | $2.2B |
| Selling, general and administrative | $976.0M | $898.0M | $865.0M | $771.0M |
| Other | $68.0M | $29.0M | — | $0 |
| Total costs and expenses | $8.3B | $8.3B | $8.9B | $7.6B |
| Operating income | $1.6B | $2.3B | $3.4B | $2.8B |
| Interest expense | ($178.0M) | ($171.0M) | ($169.0M) | ($168.0M) |
| Investment and other income, net | $1.0B | $94.0M | $350.0M | $358.0M |
| Income before income taxes | $2.5B | $2.2B | $3.5B | $3.0B |
| Income tax (expense) benefit | ($460.0M) | $5.1B | ($543.0M) | ($286.0M) |
| Net income | $2.0B | $7.4B | $3.0B | $2.7B |
| Basic earnings per share | $1.89 | $6.92 | $2.81 | $2.44 |
| Diluted earnings per share | $1.87 | $6.88 | $2.78 | $2.43 |
| Basic | 1.1B | 1.1B | 1.1B | 1.1B |
| Diluted | 1.1B | 1.1B | 1.1B | 1.1B |
| Line item | Sep 28, 2025 · FY | Sep 29, 2024 · FY | Sep 24, 2023 · FY | Sep 25, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $5.5B | $7.8B | $8.4B | $2.8B |
| Restricted cash | $2.3B | — | — | — |
| Marketable securities | $4.6B | $5.5B | $2.9B | $3.6B |
| Accounts receivable, net | $4.3B | $3.9B | $3.2B | $5.6B |
| Inventories | $6.5B | $6.4B | $6.4B | $6.3B |
| Other current assets | $2.4B | $1.6B | $1.2B | $1.6B |
| Total current assets | $25.8B | $25.2B | $22.5B | $20.7B |
| Deferred tax assets | $743.0M | $5.2B | $3.3B | $1.8B |
| Property, plant and equipment, net | $4.7B | $4.7B | $5.0B | $5.2B |
| Goodwill | $11.4B | $10.8B | $10.6B | $10.5B |
| Other intangible assets, net | $1.1B | $1.2B | $1.4B | $1.9B |
| Other assets | $6.5B | $8.1B | $8.1B | $7.7B |
| Total assets | $50.1B | $55.2B | $51.0B | $49.0B |
| Trade accounts payable | $2.8B | $2.6B | $1.9B | $3.8B |
| Payroll and other benefits related liabilities | $1.8B | $1.8B | $1.7B | $1.5B |
| Unearned revenues | $358.0M | $297.0M | $293.0M | $369.0M |
| Short-term debt | $0 | $1.4B | $914.0M | $1.9B |
| Other current liabilities | $4.2B | $4.4B | $4.5B | $3.7B |
| Total current liabilities | $9.1B | $10.5B | $9.6B | $11.9B |
| Unearned revenues | $71.0M | $88.0M | $99.0M | $144.0M |
| Long-term debt | $14.8B | $13.3B | $14.5B | $13.5B |
| Other liabilities | $4.9B | $5.0B | $4.1B | $3.9B |
| Total liabilities | $28.9B | $28.9B | $29.5B | $31.0B |
| Preferred stock, $0.0001 par value; 8 shares authorized; none outstanding | 0 | 0 | 0 | 0 |
| Preferred Stock, Par or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock, Shares Authorized | 8.0M | 8.0M | 8.0M | 8.0M |
| Preferred Stock, Shares Outstanding | 0 | 0 | 0 | 0 |
| Common stock and paid-in capital, $0.0001 par value; 6,000 shares authorized; 1,074 and 1,113 shares issued and outstanding, respectively | 0 | 0 | 490.0M | 195.0M |
| Common Stock, Par or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock, Shares Authorized | 6.0B | 6.0B | 6.0B | 6.0B |
| Common Stock, Shares, Issued | 1.1B | 1.1B | 1.1B | 1.1B |
| Retained earnings | $20.6B | $25.7B | $20.7B | $17.8B |
| Accumulated other comprehensive income | $560.0M | $587.0M | $358.0M | ($22.0M) |
| Total stockholders’ equity | $21.2B | $26.3B | $21.6B | $18.0B |
| Total liabilities and stockholders’ equity | $50.1B | $55.2B | $51.0B | $49.0B |
| Line item | Jun 28, 2026 | Mar 29, 2026 | Dec 28, 2025 | Jun 29, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $4.5B | $5.4B | $7.2B | $5.4B |
| Restricted cash | $0 | $0 | $0 | $2.3B |
| Marketable securities | $3.8B | $4.4B | $4.6B | $4.6B |
| Accounts receivable, net | $4.7B | $4.3B | $4.2B | $3.4B |
| Inventories | $8.4B | $7.4B | $6.7B | $6.3B |
| Other current assets | $1.7B | $1.6B | $2.0B | $2.8B |
| Total current assets | $23.0B | $23.1B | $24.6B | $24.9B |
| Deferred tax assets | $5.7B | $6.0B | — | $6.1B |
| Property, plant and equipment, net | $5.2B | $5.1B | $4.9B | $4.5B |
| Goodwill | $14.3B | $14.3B | $14.2B | $11.4B |
| Other intangible assets, net | $1.5B | $1.6B | $1.6B | $1.2B |
| Other assets | $7.7B | $7.2B | $7.7B | $6.8B |
| Total assets | $57.4B | $57.1B | $53.0B | $54.9B |
| Trade accounts payable | $2.9B | $3.0B | $2.7B | $2.3B |
| Payroll and other benefits related liabilities | $1.5B | $1.4B | $1.5B | $1.6B |
| Unearned revenues | $280.0M | $323.0M | $379.0M | $285.0M |
| Short-term debt | $2.5B | $498.0M | — | $0 |
| Other current liabilities | $4.3B | $4.6B | $5.2B | $3.6B |
| Total current liabilities | $11.4B | $9.8B | $9.8B | $7.8B |
| Unearned revenues | $81.0M | $70.0M | $79.0M | $93.0M |
| Long-term debt | $12.8B | $14.8B | $14.8B | $14.8B |
| Other liabilities | $5.4B | $5.2B | $5.2B | $5.0B |
| Total liabilities | $29.7B | $29.9B | $30.0B | $27.7B |
| Preferred stock, $0.0001 par value; 8 shares authorized; none outstanding | 0 | 0 | 0 | 0 |
| Preferred stock, par value | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred stock, shares authorized | 8.0M | 8.0M | 8.0M | 8.0M |
| Preferred stock, shares outstanding | 0 | 0 | 0 | 0 |
| Common stock and paid-in capital, $0.0001 par value; 6,000 shares authorized; 1,057 and 1,074 shares issued and outstanding, respectively | 0 | 0 | 0 | 0 |
| Common stock, par value | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock, shares authorized | 6.0B | 6.0B | 6.0B | 6.0B |
| Common stock, shares, issued | 1.1B | 1.1B | 1.1B | 1.1B |
| Common stock, shares, outstanding | 1.1B | 1.1B | 1.1B | 1.1B |
| Retained earnings | $27.3B | $26.9B | $22.5B | $26.6B |
| Accumulated other comprehensive income | $395.0M | $377.0M | $575.0M | $657.0M |
| Total stockholders’ equity | $27.7B | $27.3B | $23.1B | $27.2B |
| Total liabilities and stockholders’ equity | $57.4B | $57.1B | $53.0B | $54.9B |
| Line item | Sep 28, 2025 · FY | Sep 29, 2024 · FY | Sep 24, 2023 · FY | Sep 25, 2022 · FY |
|---|---|---|---|---|
| Income from continuing operations | $5.5B | $10.1B | $7.3B | $13.0B |
| Depreciation and amortization expense | $1.6B | $1.7B | $1.8B | $1.8B |
| Indefinite and long-lived asset impairment charges | $17.0M | $7.0M | $182.0M | — |
| Income tax provision in excess of (less than) income tax payments | $4.0B | ($3.1B) | ($1.3B) | ($138.0M) |
| Share-based compensation expense | $2.8B | $2.6B | $2.5B | $2.0B |
| Net gains on marketable securities and other investments | ($381.0M) | ($349.0M) | ($152.0M) | $432.0M |
| Impairment losses on other investments | $113.0M | $79.0M | $132.0M | — |
| Other items | ($57.0M) | ($67.0M) | $25.0M | ($54.0M) |
| Accounts receivable, net | ($365.0M) | ($768.0M) | $2.5B | ($2.1B) |
| Inventories | ($138.0M) | $13.0M | $8.0M | ($3.1B) |
| Other assets | $971.0M | $230.0M | $603.0M | ($2.3B) |
| Trade accounts payable | $119.0M | $682.0M | ($1.9B) | $1.0B |
| Payroll, benefits and other liabilities | ($235.0M) | $1.0B | $1.0M | ($1.0B) |
| Unearned revenues | $62.0M | $20.0M | ($56.0M) | ($324.0M) |
| Net cash used by operating activities from discontinued operations | $0 | ($91.0M) | ($399.0M) | ($170.0M) |
| Net cash provided by operating activities | $14.0B | $12.2B | $11.3B | $9.1B |
| Capital expenditures | ($1.2B) | ($1.0B) | ($1.4B) | ($2.3B) |
| Purchases of debt and equity marketable securities | ($4.7B) | ($5.1B) | ($668.0M) | ($1.4B) |
| Proceeds from sales and maturities of debt and equity marketable securities | $5.8B | $2.7B | $1.6B | $2.6B |
| Acquisitions and other investments, net of cash acquired | ($743.0M) | ($254.0M) | ($235.0M) | ($4.9B) |
| Proceeds from sales of property, plant and equipment | $14.0M | $10.0M | $127.0M | — |
| Proceeds from other investments | $61.0M | $88.0M | $20.0M | $132.0M |
| Other items | ($1.0M) | ($36.0M) | $19.0M | $30.0M |
| Net cash provided by investing activities from discontinued operations | $0 | $2.0M | $1.4B | — |
| Net cash (used) provided by investing activities | ($800.0M) | ($3.6B) | $762.0M | ($5.8B) |
| Proceeds from short-term debt | $998.0M | $799.0M | $5.1B | $7.0B |
| Repayment of short-term debt | ($998.0M) | ($799.0M) | ($5.6B) | ($7.0B) |
| Proceeds from long-term debt | $1.5B | $0 | $1.9B | $1.5B |
| Repayment of long-term debt | ($1.4B) | ($914.0M) | $1.4B | ($1.5B) |
| Proceeds from issuance of common stock | $404.0M | $383.0M | $434.0M | $356.0M |
| Repurchases and retirements of common stock | ($8.8B) | ($4.1B) | ($3.0B) | ($3.1B) |
| Dividends paid | ($3.8B) | ($3.7B) | ($3.5B) | ($3.2B) |
| Payments of tax withholdings related to vesting of share-based awards | ($1.1B) | ($932.0M) | ($521.0M) | ($766.0M) |
| Other items | ($11.0M) | ($17.0M) | ($19.0M) | ($30.0M) |
| Net cash provided (used) by financing activities from discontinued operations | $0 | $19.0M | ($58.0M) | — |
| Net cash used by financing activities | ($13.2B) | ($9.3B) | ($6.7B) | ($7.2B) |
| Effect of exchange rate changes on cash and cash equivalents | ($22.0M) | $12.0M | $30.0M | ($113.0M) |
| Net (decrease) increase in total cash, cash equivalents and restricted cash | ($6.0M) | ($678.0M) | $5.4B | ($4.0B) |
| Total cash and cash equivalents at beginning of period (including $77 and $326 classified as held for sale at September 24, 2023 and September 25, 2022) | $7.8B | $8.5B | — | — |
| Total cash and cash equivalents at end of period (including $2,323 classified as restricted cash at September 28, 2025 and $77 classified as held for sale at September 24, 2023) | $7.8B | — | — | — |
| Beginning Balance - Restricted Cash | $0 | — | — | — |
| Ending Balance - Restricted Cash | $2.3B | — | — | — |
| Line item | Jun 28, 2026 · YTD | Mar 29, 2026 · YTD | Dec 28, 2025 · Q1 | Jun 29, 2025 · YTD |
|---|---|---|---|---|
| Net income | $12.4B | $10.4B | $3.0B | $8.7B |
| Depreciation and amortization expense | $1.2B | $806.0M | $393.0M | $1.2B |
| Income tax payments in excess of income tax provision | ($5.5B) | ($5.9B) | $291.0M | ($1.5B) |
| Share-based compensation expense | $2.6B | $1.7B | $888.0M | $2.1B |
| Net gains on marketable securities and other investments | ($933.0M) | ($47.0M) | ($165.0M) | ($297.0M) |
| Impairment losses on other investments | $61.0M | — | — | $93.0M |
| Equity in net earnings of investees | ($149.0M) | ($83.0M) | — | — |
| Other items | ($52.0M) | ($47.0M) | ($40.0M) | ($23.0M) |
| Accounts receivable, net | ($264.0M) | $58.0M | $243.0M | $535.0M |
| Inventories | ($1.8B) | ($802.0M) | ($99.0M) | $33.0M |
| Other assets | $777.0M | $1.0B | $553.0M | $361.0M |
| Trade accounts payable | $149.0M | $229.0M | ($73.0M) | ($220.0M) |
| Payroll, benefits and other liabilities | $231.0M | $208.0M | $100.0M | ($943.0M) |
| Unearned revenues | ($225.0M) | ($194.0M) | ($130.0M) | $3.0M |
| Net cash provided by operating activities | $8.4B | $7.4B | $5.0B | $10.0B |
| Capital expenditures | ($1.6B) | ($1.1B) | ($549.0M) | ($785.0M) |
| Purchases of debt and equity marketable securities | ($2.4B) | ($1.9B) | ($883.0M) | ($3.8B) |
| Proceeds from sales and maturities of debt and equity marketable securities | $3.9B | $2.0B | $767.0M | $4.9B |
| Acquisitions and other investments, net of cash acquired | ($1.6B) | ($1.2B) | ($1.1B) | ($711.0M) |
| Proceeds from other investments | $26.0M | — | — | $53.0M |
| Other items | $30.0M | $38.0M | $34.0M | $7.0M |
| Net cash used by investing activities | ($1.6B) | ($2.2B) | ($1.7B) | ($329.0M) |
| Proceeds from short-term debt | $3.2B | $1.2B | $0 | $998.0M |
| Repayment of short-term debt | ($2.7B) | ($750.0M) | $0 | ($998.0M) |
| Repayment of debt of acquired company | ($174.0M) | ($174.0M) | — | — |
| Proceeds from long-term debt | $0 | — | — | $1.5B |
| Repayment of long-term debt | $0 | — | — | ($1.4B) |
| Proceeds from issuance of common stock | $223.0M | $0 | — | $201.0M |
| Repurchases and retirements of common stock | ($6.8B) | ($5.4B) | ($2.6B) | ($6.3B) |
| Dividends paid | ($2.9B) | ($1.9B) | ($949.0M) | ($2.8B) |
| Payments of tax withholdings related to vesting of share-based awards | ($888.0M) | ($536.0M) | ($280.0M) | ($878.0M) |
| Other items | ($28.0M) | ($24.0M) | ($3.0M) | ($10.0M) |
| Net cash used by financing activities | ($10.0B) | ($7.6B) | ($3.9B) | ($9.8B) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | ($21.0M) | ($25.0M) | $0 | ($5.0M) |
| Net decrease in total cash, cash equivalents and restricted cash | ($3.3B) | ($2.4B) | ($638.0M) | ($78.0M) |
| Total cash and cash equivalents at beginning of period (including $2,323 classified as restricted cash at September 28, 2025) | $7.8B | $7.8B | $7.8B | $7.8B |
| Total cash and cash equivalents at end of period | $4.5B | $5.4B | $7.2B | — |
| Beginning Balance - Restricted Cash | $2.3B | $2.3B | $2.3B | $2.3B |
| Ending Balance - Restricted Cash | $0 | $0 | $0 | — |
QUALCOMM Incorporated score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.